New Rochelle, NY, December 2, 2013–The Genetics Policy Institute (GPI) will bestow its 2013 Education Award on Mary Ann Liebert, President and CEO of the company that bears her name, citing her work in educating patients, researchers, and the broader stem cell community, and in raising the standard in medical research journalism. Ms. Liebert is the president and CEO of Mary Ann Liebert, Inc., a media empire known for establishing authoritative peer-reviewed journals in promising areas of science and biomedical research. Its biotechnology trade magazine, Genetic Engineering & Biotechnology News (GEN), debuted in 1980, was the first in its field, and is today the industry’s most widely read publication worldwide. Stem Cells and Development is an authoritative peer-reviewed journal dedicated to developments in the biology, characteristics, and therapeutic utility of stem cells. Many journals she publishes intersect the field of regenerative medicine, contributing to the scholarship and advancing stem cell science. Ms. Liebert is also the founder and executive vice president of the Rosalind Franklin Society, which recognizes and advances important contributions made by women in the life sciences.
Recent Posts
- Infant becomes world’s first patient to undergo personalized gene-editing treatment
- Biotech Tango dances away from preclinical work to extend cash runway, while Avalo lays out spending options
- Embryonic macrophages found to control blood stem cell numbers in bone marrow
- Federal appeals court sends CRISPR-Cas9 patent case back to patent office for reconsideration
- The stem cell race for Parkinson’s disease: Recent studies show significant promise
- New Cell Therapy For Resistant Hodgkins Patients